CO6791611A2 - Tableta dispersable en forma oral - Google Patents

Tableta dispersable en forma oral

Info

Publication number: CO6791611A2
Authority: CO; Colombia
Prior art keywords: dispersible tablet; orally dispersible; orally; tablet; dispersible
Prior art date: 2011-01-17

Application number

CO13195977A

Other languages

English (en)

Inventor

Yutaka Tanoue

Tetsuya Matsuura

Yutaka Yamagata

Naoki Nagahara

Original Assignee

Takeda Pharmaceutical

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2011-01-17

Filing date

2013-08-16

Publication date

2013-11-14

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45567081&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO6791611(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2013-08-16 Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical

2013-11-14 Publication of CO6791611A2 publication Critical patent/CO6791611A2/es

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2063—Proteins, e.g. gelatin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
- A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
- C07D307/81—Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Nutrition Science (AREA)
Physiology (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychiatry (AREA)
Zoology (AREA)
Pain & Pain Management (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

CO13195977A 2011-01-17 2013-08-16 Tableta dispersable en forma oral CO6791611A2 (es)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP2011007371		2011-01-17
JP2011227333		2011-10-14

Publications (1)

Publication Number	Publication Date
CO6791611A2 true CO6791611A2 (es)	2013-11-14

Family

ID=45567081

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CO13195977A CO6791611A2 (es)	2011-01-17	2013-08-16	Tableta dispersable en forma oral

Country Status (23)

Country	Link
US (6)	US20120282191A1 (es)
EP (1)	EP2665465A1 (es)
JP (3)	JP5600747B2 (es)
KR (1)	KR20140014134A (es)
CN (1)	CN103429223A (es)
AR (1)	AR084865A1 (es)
AU (1)	AU2012207818B2 (es)
BR (1)	BR112013017600A2 (es)
CA (1)	CA2824430A1 (es)
CL (1)	CL2013002033A1 (es)
CO (1)	CO6791611A2 (es)
CR (1)	CR20130380A (es)
EA (1)	EA201391053A1 (es)
EC (1)	ECSP13012825A (es)
IL (1)	IL227357A0 (es)
MA (1)	MA34908B1 (es)
MX (1)	MX2013008314A (es)
PE (1)	PE20140255A1 (es)
SG (1)	SG191964A1 (es)
TW (1)	TW201309347A (es)
UY (1)	UY33869A (es)
WO (1)	WO2012099260A1 (es)
ZA (1)	ZA201305567B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9532952B2 (en)	2011-01-28	2017-01-03	Physician's Seal, LLC	Controlled-release compositions of melatonin combined with sedative and/or analgesic ingredients
WO2012103411A2 (en)	2011-01-28	2012-08-02	Zx Pharma, Llc	Controlled-release melatonin composition and related methods
JP6245677B2 (ja) *	2012-01-20	2017-12-13	ニプロ株式会社	口腔内崩壊錠
CN103989643B (zh) *	2013-07-26	2018-10-30	武汉先路医药科技有限公司	含有雷美替胺和共聚维酮的片剂
ES2706481T3 (es) *	2013-07-31	2019-03-29	Intelgenx Corp	Forma de dosificación en película oral humectable de forma instantánea sin tensioactivo o polialcohol
CN115671064A (zh) *	2014-02-07	2023-02-03	讯唐制药公司	全天然无毒舌下药物递送系统
CN105853379A (zh) *	2016-03-31	2016-08-17	北京万全德众医药生物技术有限公司	一种雷美替胺分散片及其制备工艺
CN106389361A (zh) *	2016-03-31	2017-02-15	北京万全德众医药生物技术有限公司	一种含有雷美替胺的口腔崩解片及其制备方法
BR112018072795A2 (pt)	2016-05-06	2019-04-30	Physician's Seal, LLC	composição de valeriana e métodos relacionados
CN106038502A (zh) *	2016-07-01	2016-10-26	北京万全德众医药生物技术有限公司	一种雷美替胺口崩片及其制备方法
US20210113456A1 (en) *	2017-07-13	2021-04-22	Maxinase Life Sciences Limited	Pharmaceutical compositions of ramelteon and methods of use thereof
BR112020021852A2 (pt)	2018-05-02	2021-02-23	Ferring B.V.	formulações farmacêuticas aperfeiçoadas
JP7552146B2 (ja)	2019-08-28	2024-09-18	小野薬品工業株式会社	イバブラジンを含有する錠剤
CN113243444A (zh) *	2020-02-13	2021-08-13	罗盖特公司	作为口香糖中的填充剂的多孔淀粉
CN115778925A (zh) *	2022-12-26	2023-03-14	湖北广济医药科技有限公司	一种雷美替胺口溶膜剂及其制备方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6034239A (en)	1996-03-08	2000-03-07	Takeda Chemical Industries, Ltd.	Tricyclic compounds, their production and use
JP2884153B2 (ja) *	1996-03-08	1999-04-19	武田薬品工業株式会社	三環性化合物、その製造法および剤
CN1154479C (zh)	1996-06-14	2004-06-23	协和发酵工业株式会社	口腔内快速崩解片剂
JP3460538B2 (ja)	1997-10-08	2003-10-27	救急薬品工業株式会社	速溶性フィルム製剤
CA2587022A1 (en) *	1998-05-18	1999-11-25	Takeda Pharmaceutical Company Limited	Orally disintegrable tablets
CA2360102C (en)	1999-02-15	2009-05-19	Sumitomo Pharmaceuticals Co., Ltd.	Tablets disintegrating rapidly in the oral cavity
DE60044134D1 (de) *	1999-08-26	2010-05-20	Takeda Pharmaceutical	Nasenschleimhaut haftende matrix
JP4802436B2 (ja)	2000-04-12	2011-10-26	Ｍｓｄ株式会社	口腔内崩壊型組成物及び口腔内崩壊型製剤
US7008642B1 (en) *	2001-02-12	2006-03-07	Advanced Cardiovascular Systems, Inc.	Compositions for achieving a therapeutic effect in an anatomical structure and methods of using the same
US20050202082A1 (en) *	2001-09-28	2005-09-15	Tsuneyuki Hibino	Press-coated molded article undergoing quick disintegration
FR2834890B1 (fr)	2002-01-23	2004-02-27	Servier Lab	Composition pharmaceutique orodispersible d'agomelatine
US20040161459A1 (en) *	2002-12-31	2004-08-19	Ngoc Do	Fast-dissolve tablet technology
WO2005063240A1 (en) *	2003-12-22	2005-07-14	The Brigham And Women's Hospital, Inc.	Methods and compositions for treatment of hypertension
AU2006231752B2 (en) *	2005-04-04	2012-03-01	Takeda Pharmaceutical Company Limited	Preventive or remedy for depression or anxiety neurosis
WO2007010173A1 (en) *	2005-07-18	2007-01-25	Colin Lawrence Amess	Electrostatic air filter
PE20070698A1 (es) *	2005-11-14	2007-08-17	Teijin Pharma Ltd	Comprimido de disgregacion rapida intraoral que contiene hidrocloruro de ambroxol
FR2894475B1 (fr) *	2005-12-14	2008-05-16	Servier Lab	Composition pharmaceutique orodispersible pour administra- -tion oromucosale ou sublinguale d'agomelatine
WO2007074856A1 (ja) *	2005-12-28	2007-07-05	Takeda Pharmaceutical Company Limited	口腔内崩壊性固形製剤の製造法
EP2029136A4 (en) *	2006-05-22	2010-01-06	Vanda Pharmaceuticals Inc	TREATMENT FOR DEPRESSION DISEASES
US7797869B2 (en) *	2006-07-10	2010-09-21	Tollis David R	Multi-section display and utility stanchion
WO2008083204A2 (en) *	2006-12-28	2008-07-10	Braincells, Inc.	Modulation of neurogenesis by melatoninergic ligands
CA2680536A1 (en) *	2007-03-13	2008-10-09	Dainippon Sumitomo Pharma Co., Ltd.	Oral disintegrating tablet
AU2008239683B2 (en) *	2007-04-11	2014-03-27	Pharmaceuticals Productions Inc	Melatonin tablet and methods of preparation and use
WO2009060318A2 (en) *	2007-07-12	2009-05-14	Teva Pharmaceutical Industries Ltd.	Polymorphic forms of ramelteon and processes for preparation thereof
JP2009114113A (ja) *	2007-11-06	2009-05-28	Nipro Corp	口腔内崩壊錠及びその製造方法
JP2009136240A (ja)	2007-12-10	2009-06-25	Lion Corp	チューインガム組成物
JP2011522886A (ja)	2008-06-11	2011-08-04	アストラゼネカ・アクチエボラーグ	（２ｓ）−（４ｅ）−ｎ−メチル−５−（３−（５−イソプロポキシピリジン）イル）−４−ペンテン−２−アミンを含む舌下組成物
US7833819B2 (en) *	2008-07-23	2010-11-16	Aptina Imaging Corporation	Method and apparatus for decreasing storage node parasitic charge in active pixel image sensors
US8555875B2 (en) *	2008-12-23	2013-10-15	Map Pharmaceuticals, Inc.	Inhalation devices and related methods for administration of sedative hypnotic compounds
JP2011007371A (ja)	2009-06-23	2011-01-13	Sanyo Electric Co Ltd	空気調和機
JP5513936B2 (ja) *	2010-03-10	2014-06-04	全星薬品工業株式会社	口腔内崩壊製剤
JP5523913B2 (ja)	2010-04-21	2014-06-18	スタンレー電気株式会社	光源装置および照明装置

2012
- 2012-01-16 CA CA2824430A patent/CA2824430A1/en not_active Abandoned
- 2012-01-16 MX MX2013008314A patent/MX2013008314A/es unknown
- 2012-01-16 WO PCT/JP2012/051279 patent/WO2012099260A1/en active Application Filing
- 2012-01-16 UY UY0001033869A patent/UY33869A/es not_active Application Discontinuation
- 2012-01-16 MA MA36182A patent/MA34908B1/fr unknown
- 2012-01-16 JP JP2012535507A patent/JP5600747B2/ja not_active Expired - Fee Related
- 2012-01-16 AU AU2012207818A patent/AU2012207818B2/en not_active Ceased
- 2012-01-16 EP EP12702894.2A patent/EP2665465A1/en not_active Withdrawn
- 2012-01-16 KR KR1020137021442A patent/KR20140014134A/ko not_active Application Discontinuation
- 2012-01-16 BR BR112013017600A patent/BR112013017600A2/pt not_active IP Right Cessation
- 2012-01-16 EA EA201391053A patent/EA201391053A1/ru unknown
- 2012-01-16 US US13/261,266 patent/US20120282191A1/en not_active Abandoned
- 2012-01-16 AR ARP120100142A patent/AR084865A1/es unknown
- 2012-01-16 TW TW101101549A patent/TW201309347A/zh unknown
- 2012-01-16 PE PE2013001568A patent/PE20140255A1/es not_active Application Discontinuation
- 2012-01-16 CN CN2012800138646A patent/CN103429223A/zh active Pending
- 2012-01-16 SG SG2013053772A patent/SG191964A1/en unknown
- 2012-10-09 US US13/647,784 patent/US8642648B2/en not_active Expired - Fee Related
- 2012-10-09 US US13/647,788 patent/US8642649B2/en not_active Expired - Fee Related
2013
- 2013-07-07 IL IL227357A patent/IL227357A0/en unknown
- 2013-07-12 CL CL2013002033A patent/CL2013002033A1/es unknown
- 2013-07-23 ZA ZA2013/05567A patent/ZA201305567B/en unknown
- 2013-08-07 CR CR20130380A patent/CR20130380A/es unknown
- 2013-08-13 EC ECSP13012825 patent/ECSP13012825A/es unknown
- 2013-08-16 CO CO13195977A patent/CO6791611A2/es not_active Application Discontinuation
2014
- 2014-01-30 US US14/168,400 patent/US20140235879A1/en not_active Abandoned
- 2014-01-30 US US14/168,392 patent/US20140235709A1/en not_active Abandoned
- 2014-07-01 JP JP2014136302A patent/JP2014198723A/ja active Pending
2016
- 2016-01-15 JP JP2016006663A patent/JP2016053094A/ja active Pending
- 2016-11-18 US US15/355,357 patent/US20170065553A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20140235709A1 (en)	2014-08-21
IL227357A0 (en)	2013-09-30
AU2012207818A1 (en)	2013-05-02
NZ613265A (en)	2015-08-28
EA201391053A1 (ru)	2013-12-30
WO2012099260A1 (en)	2012-07-26
CR20130380A (es)	2013-10-09
CN103429223A (zh)	2013-12-04
ECSP13012825A (es)	2013-10-31
KR20140014134A (ko)	2014-02-05
BR112013017600A2 (pt)	2016-10-18
PE20140255A1 (es)	2014-03-11
US8642649B2 (en)	2014-02-04
JP2013544230A (ja)	2013-12-12
UY33869A (es)	2012-08-31
JP5600747B2 (ja)	2014-10-01
MX2013008314A (es)	2013-09-26
US20140235879A1 (en)	2014-08-21
US8642648B2 (en)	2014-02-04
SG191964A1 (en)	2013-08-30
EP2665465A1 (en)	2013-11-27
ZA201305567B (en)	2014-10-29
US20120282191A1 (en)	2012-11-08
CA2824430A1 (en)	2012-07-26
US20170065553A1 (en)	2017-03-09
CL2013002033A1 (es)	2014-01-03
US20130035385A1 (en)	2013-02-07
AR084865A1 (es)	2013-07-10
AU2012207818B2 (en)	2015-05-14
JP2014198723A (ja)	2014-10-23
US20130035384A1 (en)	2013-02-07
MA34908B1 (fr)	2014-02-01
JP2016053094A (ja)	2016-04-14
TW201309347A (zh)	2013-03-01

Publication	Publication Date	Title
CO6791611A2 (es)	2013-11-14	Tableta dispersable en forma oral
HK1225624A1 (zh)	2017-09-15	口腔可分散膜
BR112013014361A2 (pt)	2016-09-27	forma de dosagem
BR112013014875A2 (pt)	2016-10-18	tablete oralmente desintegrável
BRPI1008023A2 (pt)	2016-03-15	forma de dosagem sólida
DK2632598T3 (da)	2014-07-21	Valsemølle
DE112011103161A5 (de)	2013-06-20	Verteilergetriebe
ZA201304366B (en)	2014-02-26	Orally disintegrating tablet
DE112012005428A5 (de)	2014-09-25	Doppelkupplung
DK2640582T3 (da)	2014-08-18	Rulle
DE112012002988A5 (de)	2014-03-27	Doppelkupplung
HK1221899A1 (zh)	2017-06-16	口腔崩解片
BR112012031102A2 (pt)	2015-09-22	forma de dosagem oral sólida
EP2702995A4 (en)	2014-11-26	FAST RESOLVING ORAL TABLET
DK2342018T3 (da)	2013-08-26	Valsemølle
EP2612657A4 (en)	2014-05-07	TABLET WITH ORAL DISINTEGRATION
BR112013000298A2 (pt)	2016-05-31	tablete
IT1403942B1 (it)	2013-11-08	Rullo di rinvio
PT2683340T (pt)	2016-07-13	Dispositivo oral
ES1072711Y (es)	2010-12-13	Toallita masturbadora
ES1076284Y (es)	2012-05-22	Profilactico oral femenino
UY4017Q (es)	2011-01-31	Conos higienicos femeninos
ITVR20120063A1 (it)	2013-05-25	Raccordo per tubi
TH122459B (th)	2013-03-29	ข้อต่อท่อ
TH117567B (th)	2012-11-21	ข้อต่อท่อ

Legal Events

Date	Code	Title	Description
2015-07-30	FC	Application refused